Skip Ribbon Commands
Skip to main content
Translate
Donations
menu iconMenu
search iconSearch

UC San Diego Neuroscientist Honored with Prestigious MetLife Foundation Award

 

February 25, 2010  |  

Dr. Edward Koo among four recognized in Washington, DC, for research in Alzheimer's disease

Edward H. Koo, MD, professor of neurosciences at the University of California, San Diego School of Medicine was among four scientists honored at a luncheon in Washington, D.C. on February 25 for their work on complementary approaches to Alzheimer’s research. Koo is also co-director of the Shiley-Marcos Alzheimer’s Disease Research Center at UC San Diego, one of the five original centers for Alzheimer’s research established by the National Institute on Aging.    


Edward H. Koo, MD, professor of neurosciences at the University of California, San Diego

Koo’s lab focuses on understanding the pathophysiology of Alzheimer’s disease, with the hope of translating findings from basic cell and molecular biological studies to the clinical setting, to better understand the causes of the disease or have an impact on treatments.  Koo has also been recognized for his studies on characterizing the pathways of production of the amyloid beta-protein from the amyloid precursor protein (APP).  He has investigated the physiological function of the APP and how it might contribute to Alzheimer pathogenesis in ways unrelated to amyloid production.  More recently, he has focused his attention on how synapses are damaged in Alzheimer’s disease.  

According to recent estimates, more than 26 million people worldwide are believed to be living with Alzheimer’s disease. In the United States, as many as 5.3 million Americans have Alzheimer’s, and it is the seventh leading cause of death.  It is estimated that the number of people with Alzheimer’s will increase to 7.7 million by the year 2030, unless the disease can be effectively treated, delayed, or prevented.

Joining Koo in receiving the prestigious MetLife Foundation Awards for Medical Research in Alzheimer’s disease were Todd E. Golde, MD, PhD, professor of neuroscience at the University of Florida and director of its Center for Translational Research in Neurodegenerative Diseases; and Eva-Maria Mandelkow, MD and Director Eckhard Mandelkow, MD, both of Hamburg, Germany’s Max-Planck-Institute for Structural Molecular Biology.

This year’s recipients are examples of how differing schools of thought can come together to solve some of the medical science’s most vexing problems. For instance, Koo and Golde worked together to identify the gamma-secretase modulators that decrease production of a highly toxic type of amino acid which holds great promise for drug therapies to treat or prevent Alzheimer’s. 

“UC San Diego School of Medicine embraces collaboration across disciplines and organizations – partnerships  which promote research in areas of need such as Alzheimer’s disease where a cure or treatment is critically needed,” said William C. Mobley, MD, PhD, Chair and Professor of UCSD’s Department of Neurosciences. “Dr. Koo’s work is a remarkable example of a partnership that has created a path toward discovery.”

Since 1986, MetLife Foundation has granted major awards to scientists who have demonstrated significant contributions to the understanding of Alzheimer's disease. The program’s goal is to recognize the importance of basic research with an emphasis on providing scientists the opportunity to pursue ideas. Each winner received a $100,000 research grant and personal prize of $25,000 to further their work.

“MetLife Foundation has long recognized the impact Alzheimer’s has on families, society and the economy,” said C. Robert Henrikson, Chairman, President and Chief Executive Officer of MetLife, Inc. “We continue our commitment to support the outstanding scientists who are making strides and developing methods to combat and, perhaps someday, prevent Alzheimer’s disease from impacting future generations.”

# # #

Media Contact: Jamee Lynn Smith, 619-543-6163, jlynnsmith@ucsd.edu




Media Contact

Related News

5/21/2015
Using human embryonic stem cells, researchers at University of California, San Diego School of Medicine and Moores Cancer Center and Sanford-Burnham Medical Research Institute created a model that all ...
5/18/2015
A binational team from the University of California, San Diego School of Medicine and the U.S.-Mexico Border Health Commission, Mexico Section has launched a new research project aimed at promoting pr ...
5/17/2015
For parents who send their kids to dance classes to get some exercise, a new study from researchers at University of California, San Diego School of Medicine suggests most youth dance classes provide ...
5/8/2015
Therapies that specifically target mutations in a person’s cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers at University of ...
5/7/2015
Researchers at University of California, San Diego School of Medicine and Shiley Eye Institute have identified the molecular “glue” that builds the brain connections that keep visual images clear and ...
5/7/2015
Writing in the May 7 online issue of American Journal of Geriatric Psychiatry, researchers at University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System su ...
5/6/2015
Each year, more than 10 million Americans seek medical attention, often in emergency situations, for symptoms of intestinal blockages. Researchers at the University California, San Diego School of Med ...
5/6/2015
With the threat of multidrug-resistant bacterial pathogens growing, new ideas to treat infections are sorely needed. Researchers at University of California, San Diego School of Medicine and Skaggs Sc ...


Share This Article



Follow Us